Embolic Protection Devices Market Report 2024

This Embolic Protection Devices market report covers industry characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The embolic protection devices market size has grown strongly in recent years. It will grow from $1.05 billion in 2023 to $1.14 billion in 2024 at a compound annual growth rate (CAGR) of 8.3%. The growth during the historic period can be attributed to a rising demand for advanced interventional techniques, an increase in the geriatric population, expansion of healthcare infrastructure, higher investment in research and development, and an increase in clinical trials.

The embolic protection devices market size is expected to see strong growth in the next few years. It will grow to $1.57 billion in 2028 at a compound annual growth rate (CAGR) of 8.4%. The growth during the forecast period can be attributed to the expanding use of embolic protection devices in various vascular procedures, an increase in complex cardiovascular interventions, a rising prevalence of cardiovascular diseases, growing adoption of minimally invasive techniques, and heightened awareness of embolic risks. Major trends expected include advancements in technology, integration of digital health technologies, personalized medicine approaches, development of bioresorbable materials, and innovations in next-generation filter technologies.

The rising prevalence of cardiovascular disorders is expected to drive growth in the embolic protection devices market. Cardiovascular disorders, including conditions such as heart attacks, strokes, and hypertension, affect the heart and blood vessels, disrupting blood circulation and causing various health issues. Urbanization often leads to lifestyle changes such as decreased physical activity, increased pollution, and higher consumption of unhealthy foods. Additionally, poor dietary choices and high obesity rates significantly contribute to cardiovascular problems. Embolic protection devices are designed to capture and remove debris that could obstruct blood flow during cardiovascular procedures, thereby reducing the risk of complications such as strokes and enhancing the safety and efficacy of these interventions. For example, the Office for National Statistics in March 2022 reported that deaths from heart attacks increased to 20,061 in 2021, up from 19,440 in 2020. This rise in cardiovascular disorders is driving demand for embolic protection devices.

Key players in the embolic protection devices market are focusing on advancing technologies to enhance the safety, effectiveness, and efficiency of cardiovascular interventions. One such innovation is the integrated 4Fr radiopaque pigtail catheter, which allows for continuous imaging and precise positioning during treatments. For instance, in March 2021, Innovative Cardiovascular Solutions, LLC, a US-based medical device company, introduced the Next Generation EMBLOK Embolic Protection System. This system is designed to reduce the risk of embolic debris during transcatheter aortic valve replacement (TAVR) procedures by providing complete circumferential aortic coverage. The EMBLOK system captures and removes debris released during TAVR procedures, preventing it from entering cerebral and peripheral circulation, thus improving patient safety and minimizing clinical complications.

In August 2022, Boston Scientific Corporation, a US-based medical technology company, acquired Obsidio Inc. for an undisclosed amount. This acquisition reflects Boston Scientific's dedication to enhancing its interventional oncology and embolization portfolio by integrating GEM technology, which improves procedural efficiency and customization for embolization treatments. Obsidio Inc. is a US-based medical device company specializing in innovative embolic products for vascular embolotherapy.

Major companies operating in the embolic protection devices market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, W L Gore & Associates Inc., Cook Medical LLC, LivaNova PLC, Cordis Corporation, MicroPort Scientific Corporation, Biotronik SE & Co. KG, Endologix LLC, Claret Medical Inc., Cardiovascular Systems Inc., Silk Road Medical Inc., CeloNova Biosciences Inc., Veryan Medical Ltd., Emboline Inc., Keystone Heart Ltd., InspireMD Inc., Innovative Cardiovascular Solutions LLC, Allium Medical Solutions Ltd., Contego Medical LLC, AngioSlide Ltd., Transverse Medical Inc.

North America was the largest region in the embolic protection devices market in 2023. The regions covered in the embolic protection devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the embolic protection devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Embolic protection devices are specialized medical tools designed to capture and remove embolic debris that might be dislodged during cardiovascular procedures, such as transcatheter aortic valve replacement (TAVR) or carotid artery stenting. These devices are essential for preventing strokes and other complications by trapping debris before it reaches critical organs.

The main types of embolic protection devices include distal filter devices, distal occlusion devices, and proximal occlusion devices. Distal filter devices are specifically designed to catch and remove embolic particles that could travel downstream during procedures, thereby preventing blockages in smaller blood vessels. These devices are used in the treatment of cardiovascular disease, neurovascular disease, and peripheral disease. They are employed by hospitals, ambulatory surgical centers, and other medical facilities.

The embolic protection devices market research report is one of a series of new reports that provides embolic protection devices market statistics, including embolic protection devices industry global market size, regional shares, competitors with a embolic protection devices market share, detailed embolic protection devices market segments, market trends and opportunities, and any further data you may need to thrive in the embolic protection devices industry. This embolic protection devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The embolic protection devices market consists of sales of filter devices, diaphragm protection devices, and guidewire-based devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.